WuXi Biologics Co. Ltd., a wholly owned subsidiary of WuXi AppTec Co. Ltd. (WuXi), and Prima BioMed Ltd. (NASDAQ: PBMD), announced that through their strategic supply partnership, Prima’s first-in-class immuno-oncology product candidate IMP321 (LAG-3 Ig fusion protein), manufactured at WuXi’s state-of-the-art cGMP facility in China, has now been dosed in a Phase IIb clinical trial in Belgium.
Prima Biomed Ltd. (NASDAQ:PBMD) belongs to Healthcare sector. Its weekly performance is -3.49%. On last trading day company shares ended up at $0.83.
The Kroger Co. (NYSE:KR) will host a conference call with investors on Thursday, March 3, 2016 at 10:00 a.m. (ET) to discuss financial results for the fourth quarter 2015.
The Kroger Co. (NYSE:KR) shares increased 1.78% in last trading session and ended the day at $40.62. KR Gross Margin is 22.10% and its return on assets is 6.40%. The Kroger Co. (NYSE:KR) quarterly performance is 7.17%.
Novavax Inc. (NASDAQ:NVAX) reported a net loss of $78.8 million, or $0.29 per share, for the fourth quarter of 2015, compared to a net loss of $31.5 million, or $0.13 per share, for the fourth quarter of 2014. For the twelve months ended December 31, 2015, the net loss was $156.9 million, or $0.60 per share, compared to a net loss of $82.9 million, or $0.37 per share, for the same period in 2014.
On 01 March, Novavax, Inc. (NASDAQ:NVAX) shares increased 7.80% and was closed at $4.70. NVAX EPS growth in last 5 year was 4.70%. Novavax, Inc. (NASDAQ:NVAX) year to date (YTD) performance is -43.98%.
New Mountain Finance Corporation (NYSE:NMFC) board of directors declared a first quarter dividend of $0.34 per share, which will be payable on March 31, 2016 to holders of record as of March 17, 2016.
New Mountain Finance Corporation (NYSE:NMFC) ended the last trading day at $12.65. Company weekly volatility is calculated as 1.99% and price to cash ratio as 32.92. New Mountain Finance Corporation (NYSE:NMFC) showed a weekly performance of 4.89%.
On 22 February, Chegg, Inc. (NYSE:CHGG) reported its fourth-quarter earnings rose to $3.63 million, or 4 cents a share, from $1.69 million, or 2 cents a share, a year earlier. Revenue fell to $68.2 million, compared with $72.1 million projected by analysts in a FactSet survey.
Chegg, Inc. (NYSE:CHGG) shares increased 4.90% in last trading session and ended the day at $4.50. CHGG Gross Margin is 37.00% and its return on assets is -19.60%. Chegg, Inc. (NYSE:CHGG) quarterly performance is -38.19%.